Drug-Eluting Stents for In-Stent Restenosis and Acute Myocardial Infarction

By Schofer Joachim   Bode Christoph   Silber Sigmund  

Herz, Vol. 29, Iss. 2, 2004-03 ,pp. : 195-200

Springer Publishing Company

Access to resources Recommend Favorite

Sirolimus-eluting stents for percutaneous coronary intervention in acute myocardial infarction: Lesson from a case-controlled comparison of bare metal versus drug-eluting stents in thrombus-laden lesions

By Weber F.   Schneider H.   Schwarz C.   Holzhausen C.   Petzsch M.   Nienaber C.  

Zeitschrift für Kardiologie, Vol. 93, Iss. 12, 2004-12 ,pp. : 938-943

Springer Publishing Company

Access to resources Recommend Favorite

Very late stent thrombosis occurring simultaneously in sirolimus-eluting stents and bare-metal stent in three different coronary vessels

By Kawaguchi Yoshitaka  

Cardiovascular Intervention and Therapeutics, Vol. 26, Iss. 1, 2011-01 ,pp. : 64-69

Springer Publishing Company

Access to resources Recommend Favorite

A no-reflow prediction model in patients with ST-elevation acute myocardial infarction and primary drug-eluting stenting

By Wang Chang-Hua   Chen Yun-Dai   Yang Xin-Chun   Wang Le-Feng   Wang Hong-Shi   Sun Zhi-Jun   Liu Hong-Bin  

Scandinavian Cardiovascular Journal, Vol. 45, Iss. 2, 2011-04 ,pp. : 98-104

Informa Healthcare

Access to resources Recommend Favorite

Drug-eluting stent thrombosis after 2029 days of placement: longest ever reported interval between drug-eluting stent placement and very late thrombosis

By Akhtar Muhammed   Waked Alain   Bhat Hilal   Khalid Mariam   Teli Sumaya   Saiful Faisal B   Lafferty James   Bhat Tariq  

Future Cardiology, Vol. 7, Iss. 6, 2011-11 ,pp. : 745-748

Future Medicine

Access to resources Recommend Favorite